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Abstract
© 2020 Selig et al. Small heat-shock proteins (sHSPs) are ubiquitously expressed molecular chaperones
that inhibit amyloid fibril formation; however, their mechanisms of action remain poorly understood.
sHSPs comprise a conserved α-crystallin domain flanked by variable N- and C-terminal regions. To
investigate the functional contributions of these three regions, we compared the chaperone activities of
various constructs of human αB-crystallin (HSPB5) and heat-shock 27-kDa protein (Hsp27, HSPB1)
during amyloid formation by α-synuclein and apolipoprotein C-II. Using an array of approaches, including
thioflavin T fluorescence assays and sedimentation analysis, we found that the N-terminal region of
Hsp27 and the terminal regions of αB-crystallin are important for delaying amyloid fibril nucleation and
for disaggregating mature apolipoprotein C-II fibrils. We further show that the terminal regions are
required for stable fibril binding by both sHSPs and for mediating lateral fibril-fibril association, which
sequesters preformed fibrils into large aggregates and is believed to have a cytoprotective function. We
conclude that although the isolated α-crystallin domain retains some chaperone activity against amyloid
formation, the flanking domains contribute additional and important chaperone activities, both in delaying
amyloid formation and in mediating interactions of sHSPs with amyloid aggregates. Both these
chaperone activities have significant implications for the pathogenesis and progression of diseases
associated with amyloid deposition, such as Parkinson's and Alzheimer's diseases.
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Small heat-shock proteins (sHSPs) are ubiquitously expressed
molecular chaperones that inhibit amyloid fibril formation;
however, their mechanisms of action remain poorly understood.
sHSPs comprise a conserved a-crystallin domain flanked by
variable N- and C-terminal regions. To investigate the functional contributions of these three regions, we compared the
chaperone activities of various constructs of human aB-crystallin (HSPB5) and heat-shock 27-kDa protein (Hsp27, HSPB1)
during amyloid formation by a-synuclein and apolipoprotein
C-II. Using an array of approaches, including thioflavin T fluorescence assays and sedimentation analysis, we found that the
N-terminal region of Hsp27 and the terminal regions of aBcrystallin are important for delaying amyloid fibril nucleation
and for disaggregating mature apolipoprotein C-II fibrils. We
further show that the terminal regions are required for stable
fibril binding by both sHSPs and for mediating lateral fibril–
fibril association, which sequesters preformed fibrils into
large aggregates and is believed to have a cytoprotective
function. We conclude that although the isolated a-crystallin domain retains some chaperone activity against amyloid
formation, the flanking domains contribute additional and
important chaperone activities, both in delaying amyloid formation and in mediating interactions of sHSPs with amyloid
aggregates. Both these chaperone activities have significant
implications for the pathogenesis and progression of diseases associated with amyloid deposition, such as Parkinson’s and Alzheimer’s diseases.

Small heat-shock proteins (sHSPs) are a major family of
heat-shock proteins, present in all kingdoms of life, that have a
low monomeric molecular mass, ranging from 15 to 40 kDa.
sHSPs generally comprise a central, ;90-residue a-crystallin
domain (ACD) and variable-length N- and C-terminal regions
(NTRs and CTRs, respectively). Despite their small monomeric
size, metazoan sHSPs are structurally diverse, often existing as
a heterogenous array of oligomeric states. The isolated ACD
typically forms a stable dimer (1–3), suggesting that the NTR and
CTR regulate higher order oligomerization (4). As a result, relaThis article contains supporting information.
* For correspondence: Michael D.W. Griffin, mgriffin@unimelb.edu.au.

tively few high-resolution structures of sHSPs have been solved.
The majority of solved structures are of the isolated ACD (1–3, 5)
or of monodisperse sHSP oligomers formed from plant and prokaryotic sHSPs (6, 7).
The human genome encodes 10 sHSPs, with gene names
HSPB1–10. Among the best studied of these are HSPB1
(heat-shock 27 kDa protein, Hsp27) and HSPB5 (aB-crystallin, aB-C), which are ubiquitously expressed (8). The sHSPs
are involved in a diverse range of cellular processes that
include regulating cell growth, differentiation, and motility
(9, 10), apoptosis (11), autophagy (12), cytoskeletal dynamics
(13, 14), and regulation of the intracellular redox state (15).
The unifying feature of sHSPs in these processes is that they
act as ATP-independent molecular chaperones. The sHSPs
can work cooperatively with ATP-dependent chaperones
to refold substrate proteins (16) or participate in shuttling
destabilized or misfolded proteins for proteolytic degradation
(17). As a result, sHSPs are a key component of protein quality control as part of cellular proteostasis. Mutations in genes
encoding sHSPs are associated with the pathology of a variety
of diseases such as neuropathies (18), myopathies (19), and
cataracts (20).
There is growing evidence that Hsp27 and aB-C are involved
in the cellular response to protein aggregation in a variety of
neurodegenerative diseases. A pathological hallmark of neurodegenerative diseases, such as Parkinson’s disease (PD) and
Alzheimer’s disease, is the intra- or extracellular aggregation of
specific proteins to form amyloid fibrils. a-Synuclein (a-syn)
and apolipoprotein C-II (apoC-II) are two examples of proteins
that form amyloid fibrils both in vitro and in vivo. apoC-II is a
serum protein found associated with very low-density lipoprotein particles where it regulates blood triglycerides. Very lowdensity lipoprotein–bound apoC-II is comprised of amphipathic a helices (21); however, lipid-free apoC-II is unstable
and prone to aggregation. Amyloid formation by apoC-II in
vitro is well-characterized (22–24), and mutations in apoC-II
cause renal amyloidosis (25, 26). The biological roles of a-syn
are not well-understood; however, it is highly expressed in
multiple regions of the brain and is thought to play a role in
vesicular trafficking and neurotransmitter release (27). Like
apoC-II, the N-terminal region of a-syn adopts an amphipathic
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a-helical conformation upon binding to membranes or lipidcontaining vesicles (28). However, a-syn aggregates to form
amyloid fibrils that are the principle proteinaceous components of Lewy bodies found in dopaminergic neurons in the
substantia nigra of PD patients (29, 30). The expression levels
of sHSPs such as Hsp27 and aB-C correlate with the degree
of dementia in the brains of Alzheimer’s disease and PD
patients (31–33). In intracellular models of PD, Hsp27 and
aB-C reduce amyloid formation by a-syn (34). In vitro, sHSPs
have been shown to inhibit amyloid formation by Ab (35),
b2-microglobulin (35), a-syn (34), tau (36), superoxide dismutase 1 (37), and apoC-II (38). Furthermore, sHSPs colocalize with deposits of aggregated proteins associated with a variety of protein misfolding diseases (39, 40), demonstrating
their role in the cellular response to amyloid formation.
The precise mechanisms by which sHSPs bind proteins to
inhibit amyloid fibril formation remain elusive. This is in
part because Hsp27 and aB-C form polydisperse oligomers
(41, 42) that exist in equilibrium with dimeric forms (4, 43).
Furthermore, serine phosphorylation in the N-terminal
region of Hsp27 and aB-C has the dual effect of regulating
both the extent to which the sHSP oligomers dissociate into
smaller species, including dimers, and their chaperone activity (44, 45), suggesting that the exchange of suboligomeric species may be important for chaperone activity.
Interestingly, the dimeric, isolated ACD of aB-C was found
to inhibit both amorphous and fibrillar protein aggregation
(5); however, potential substrate-binding sites on aB-C have
also been identified in the N- and C-terminal regions
(46–48).
To determine the importance of the regions outside the conserved ACD for the ability of Hsp27 and aB-C to inhibit amyloid fibril formation, we directly compared the chaperone activities of WT Hsp27 and aB-C with their ACD-only counterparts
against the amyloid formation of two well-characterized proteins: a-syn and apoC-II. Additionally, we investigated the
chaperone activities of a full-length Hsp27 construct with three
serine-to-aspartate mutations designed to mimic the triply
phosphorylated, dimeric form of Hsp27 (Hsp27-3D), as well as
a truncated form of this construct lacking the CTR (Hsp273DDCTR). Using in vitro aggregation assays, we show that constructs containing both the NTR and ACD more effectively
delay amyloid fibril nucleation and/or reduce the rate of fibril
elongation than ACD-only constructs. Additionally, the binding of Hsp27 to preformed fibrils and the disaggregation of
apoC-II fibrils were found to be conferred by primarily the
NTR. Similarly, the ACD-only construct of aB-C was insufficient for mediating fibril binding and apoC-II fibril disaggregation. Full-length sHSPs also induced the tangling of preformed
fibrils into larger aggregates. ACD-only constructs did not display this activity, and a construct containing only the NTR and
ACD displayed a reduced ability to tangle preformed fibrils relative to its full-length counterpart. Thus, although the ACD
retains some chaperone activity in vitro, the N- and C-terminal
regions confer distinct and important chaperone functions
against amyloid fibril formation.

Results
The effects of full-length and truncated constructs of Hsp27
and aB-C on a-syn amyloid formation in vitro
The chaperone activities of full-length and truncated sHSPs
were investigated using well-established in vitro apoC-II and
a-syn amyloid formation assays. Spontaneous fibril formation
by a-syn was induced by incubating the protein at 200 mM,
37 °C, with constant agitation. All sHSP variants delayed amyloid formation of a-syn by various degrees, with the exception
of Hsp27 ACD (Fig. 1, A–F, and Fig. S1). We did not observe a
time-dependent increase in ThT fluorescence when sHSPs
were incubated alone, and BSA did not inhibit the amyloid formation of unseeded a-syn fibril formation (Fig. S2). By fitting
the raw data to a four-parameter Boltzmann curve (Fig. S1), we
derived the duration of the lag phase (Tlag) and the time to halfmaximal ThT fluorescence (T50) (Fig. 1, G and H, respectively).
Differences in the Tlag and T50 observed across the samples
were analyzed using one-way ANOVA with post hoc Tukey
test. The full-length constructs (WT aB-C, WT Hsp27, and
Hsp27-3D) and Hsp27-3DDCTR significantly increased the
Tlag relative to a-syn incubated alone (p , 0.01), suggesting
that these constructs delay fibril nucleation. Conversely, ACDonly constructs of aB-C and Hsp27 did not significantly
increase the Tlag. All sHSP constructs except Hsp27 ACD
significantly increased the T50 (Fig. 1H), suggesting that the
rate of a-syn fibril elongation was reduced relative to a-syn
incubated alone. Table S1 shows statistical analysis of differences in Tlag and T50 between the different sHSP constructs.
This analysis shows that the chaperone activity of Hsp273DDCTR was more similar to that of WT Hsp27 and Hsp273D than to Hsp27 ACD. These findings demonstrate that
the NTR of Hsp27 and the terminal regions of aB-C are important for delaying amyloid fibril formation by a-syn in
vitro during both the nucleation phase and the elongation
phase.
Across all samples, large differences in the final ThT plateaus
were observed (Fig. 1, A–F). ThT fluorescence can be influenced by nonfibrillar structures, changes in sample viscosity,
and the morphology of amyloid fibrils (49, 50). To determine
whether the final ThT fluorescence readings correlated with
the fraction of aggregated a-syn, we used pelleting assays (38).
In these assays amyloid fibrils were pelleted through a 20% (w/
v) sucrose layer such that small, soluble proteins remained in
the supernatant fraction, whereas large oligomers such as those
formed by WT Hsp27 and aB-C entered and remained in the
sucrose layer. Thus, we were able to separate fibrils, large
oligomers, and small species (e.g. dimers and monomers) in
these assays. The supernatant, sucrose, and pellet layers as well
as a sample prior to centrifugation (total) were analyzed by
SDS-PAGE. We observed that the portion of soluble a-syn
remaining at the end of the assays appeared to be unaffected by
the presence of sHSPs (Fig. 1I). Thus, the observed differences
between the total ThT fluorescence yields for a-syn fibrils
formed alone and those formed in the presence of the sHSPs
(Fig. 1) were not due to a difference in the fraction of aggregated a-syn. Furthermore, we used transmission electron microscopy (TEM) to confirm that the ThT-reactive species
J. Biol. Chem. (2020) 295(29) 9838–9854
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Figure 1. Kinetics of unseeded a-syn amyloid formation in the presence of sHSPs. A–F, ThT-monitored amyloid formation of a-syn (200 mM) alone (black)
or in the presence of the indicated sHSP (10 mM), WT aB-C (red, A), aB-C ACD (green, B), WT Hsp27 (orange, C), Hsp27 ACD (blue, D), Hsp27-3D (magenta, E), and
Hsp27-3DDCTR (cyan, F). The samples were assayed in quadruplicate in two independent experiments. The data are presented as means 6 S.E., where n = 8. G
and H, Tlag (G) and T50 (H) values are displayed as means 6 S.D. overlaid with individual data points (n = 8). Significance values were determined using a oneway ANOVA test with a post hoc Tukey’s multiple comparisons test. *, p , 0.05; **, p , 0.01; ***, p , 0.001; ****, p , 0.0001; ns, not significant. I, unseeded
a-syn fibrils were formed alone (200 mM) or in the presence of 10 mM of the indicated sHSP construct for 48 h, 37 °C and then pelleted as described under “Experimental procedures.” The supernatant (Sup), sucrose (Suc), and pellet (P) layers were collected and analyzed by SDS-PAGE alongside the total (T) uncentrifuged samples. Also shown are controls of each sHSP construct incubated alone under identical conditions.
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formed in the presence of all sHSP constructs were fibrillar
(Fig. S3). Therefore, although the sHSP constructs reduced the
rate of a-syn amyloid formation, under these conditions the
sHSPs did not halt amyloid assembly at the nucleation stage or
significantly alter the total fraction of aggregated a-syn after 42
h, once all samples had reached a ThT fluorescence plateau.
We also confirmed that the quaternary structures of our
sHSP constructs were consistent with those observed previously (5, 45, 51) using sedimentation velocity analytical ultracentrifugation (SV-AUC) (Fig. S4 and Table S2). WT aB-C and
WT Hsp27 both predominantly form oligomers as indicated by
broad sedimentation coefficient distributions with weight-average sedimentation coefficients (s20,w) of ;12–13 S (Fig. S4, A,
C, G, and H, and Table S2). aB-C ACD and Hsp27 ACD form
dimers with s20,w values of 2.07 and 2.31 S, respectively (Fig. S4, B,
D, G, and H, and Table S2). Hsp27-3D predominantly assembles
into dimers as indicated by a major peak in the sedimentation
coefficient distribution at ;2.5 S; however, a minor peak is
observed at ;4 S, indicating the formation of small oligomers for
this sHSP construct (Fig. S4, E and H, and Table S2). Deletion of
the CTR from Hsp27-3D prevented the formation of these small
oligomers, because a single peak was observed for Hsp273DDCTR with a s20,w of 2.58 S (Fig. S4F, S4H and Table S2).
The effects of full-length and truncated constructs of Hsp27
and aB-C on a-syn and apoC-II fibril elongation
To specifically assess the effects of sHSPs on the elongation
of a-syn fibrils, we used a seeded assay (52). In these experiments, a-syn began to aggregate immediately, and a ThT fluorescence plateau was reached after ;10 h (Fig. 2A and Fig.
S5A). The non-chaperone control protein, BSA, did not inhibit
seeded a-syn fibril formation, and no time-dependent changes
in ThT fluorescence were observed for sHSPs incubated alone
(Fig. S6). Estimates of the T50 were obtained by fitting the data
to a one-phase association model (Fig. 2B and Fig. S5). All sHSP
constructs except Hsp27 ACD significantly increased T50 (Fig.
2B). The ACD-only constructs were relatively less effective at
delaying seeded a-syn fibril formation than the constructs containing the NTR (Fig. 2B). Pelleting assays indicated that the
portion of a-syn remaining soluble at the end of the assay was
likely increased by all of the sHSP constructs relative to a-syn
seeded alone (Fig. 2C). However, the enhancement of a-syn in
the supernatant and its depletion from the pellet were particularly evident for WT aB-C (Fig. 2C). These findings are consistent with the results of the seeded ThT fluorescence assay (Fig.
2A), and the relative efficacy of the sHSP constructs was comparable with the results of the unseeded assay (Fig. 1).
ApoC-II aggregates readily at room temperature without agitation or seeding (22). Consequently, a lag phase is not typically
observed for apoC-II aggregation (Fig. 2D and Fig. S7A). These
data were fit to a one-phase association model to obtain estimates of the T50 (Fig. S7). BSA did not inhibit apoC-II fibril formation, and no time-dependent changes in ThT fluorescence
were observed for sHSPs incubated alone (Fig. S8). All sHSP
constructs significantly increased the T50; thus, these constructs delayed fibril elongation by apoC-II (Fig. 2E). WT aB-C
was the most effective chaperone against fibril elongation, and

Hsp27 ACD was the least effective (Fig. 2, D and E). ACD-only
constructs were again less effective than constructs containing
the NTR with respect to increasing the T50 (Fig. 2E). TEM was
also used to confirm fibril formation by apoC-II in the absence
of sHSPs and in the presence of a subset of the sHSP constructs
(Fig. S9).
The sucrose pellet assay demonstrated that all sHSP constructs resulted in a portion of apoC-II remaining soluble at the
end of the aggregation assay, in contrast to apoC-II incubated
alone, in which we did not observe a band corresponding to
apoC-II in the supernatant (Fig. 2F). Qualitative analysis suggests that the full-length WT constructs induced the highest
proportion of soluble apoC-II remaining, followed by Hsp273D, Hsp27-3DDCTR, aB-C ACD, and Hsp27 ACD (Fig. 2F).
Taken together, these experiments indicate that constructs
containing the NTR are relatively more effective than constructs containing only the ACD against both amyloid-forming
proteins tested.
The association of sHSPs with amyloid fibrils
Our pelleting assays allow us to determine to what extent
each sHSP construct stably cosediments with apoC-II and
a-syn fibrils. Previous studies employed fluorescence and EM
to establish that the cosedimentation behavior of aB-C and
Hsp27 with apoC-II and a-syn fibrils observed in pelleting
assays is due to spatial colocalization of these sHSPs with the
fibrils (38, 40, 53). We have therefore used pelleting assays as a
high-throughput approach to monitor fibril colocalization by
sHSPs. WT Hsp27, Hsp27-3D, and WT aB-C were all found
primarily in the pellet fraction when present during the aggregation of apoC-II or a-syn (Figs. 1I and 2, C and F). Interestingly, Hsp27-3DDCTR cosedimented with both apoC-II and
a-syn fibrils to a lesser extent than WT Hsp27, suggesting that
the CTR of Hsp27 contributes to fibril binding. When incubated with elongating apoC-II fibrils, ACD-only constructs
remained primarily in the soluble fraction, suggesting that they
did not form stable associations with the fibrils at levels detectable by SDS-PAGE (Fig. 2F). Similarly, when incubated in the
presence of elongating a-syn fibrils, Hsp27 ACD remained primarily in the soluble fraction. However, aB-C ACD was found
in the pellet fraction when present during both unseeded and
seeded a-syn fibril elongation (Figs. 1I and 2C).
To further investigate the cosedimentation of each sHSP
construct with amyloid fibrils, mature preformed apoC-II and
a-syn amyloid fibrils were incubated with each sHSP construct for 72 h. The fibrils were then pelleted and analyzed
as described above. All full-length constructs and Hsp273DDCTR were located primarily in the pellet fractions, suggesting that these constructs stably associate and cosediment
with preformed apoC-II and a-syn fibrils (Fig. 3). Neither
Hsp27 ACD nor aB-C ACD cosedimented with preformed
fibrils of apoC-II or a-syn at levels detectable by SDS-PAGE.
This indicates that aB-C ACD can only associate with a-syn
fibrils when it is present during amyloid fibril elongation but
not once the mature fibrils have been formed. Taken together, these data suggest that the ACD of aB-C is
J. Biol. Chem. (2020) 295(29) 9838–9854
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Figure 2. Kinetics of seeded a-syn amyloid formation and unseeded apoC-II amyloid formation in the presence of sHSPs. A, a-syn amyloid formation
(200 mM, 5% fibril seeds, 45 °C) alone (black) or in the presence of the indicated sHSP (50 mM): aB-C WT (red), aB-C ACD (green), WT Hsp27 (orange), Hsp27 ACD
(blue), Hsp27-3D (magenta), and Hsp27-3DDCTR (cyan). The data are presented as means 6 S.E., where n = 3. Fits to the data are overlaid. The S.E. is small, and
the error bars are generally not visible. B, T50 values derived from fits to the raw data and plotted as means 6 S.D., with the individual data points shown and
n = 3. Significance values were determined using a one-way ANOVA test with a post hoc Tukey’s multiple comparisons test. ***, p , 0.001; ****, p , 0.0001; ns,
not significant. C, a-syn fibrils were formed for 24 h (200 mM, 5% fibril seeds, 45 °C) alone or in the presence of the indicated sHSP (50 mM). These samples were
then centrifuged, and the supernatant (Sup), sucrose (Suc), and pellet (P) layers were collected and analyzed by SDS-PAGE alongside a sample prior to centrifugation (total, T). Also shown are control samples of each sHSP incubated alone under identical conditions. D, apoC-II (56 mM) unseeded amyloid fibril formation
alone at 30 °C (black) or in the presence of the indicated sHSP (12.8 mM): aB-C WT (red), aB-C ACD (green), WT Hsp27 (orange), Hsp27 ACD (blue), Hsp27-3D (magenta), and Hsp27-3DDCTR (cyan). The data are presented as means 6 S.E. where n = 2 with fits to the data overlaid. The S.E. is small, and the error bars are generally not visible. E, T50 values derived from fits to the raw data and plotted as means 6 S.D. with the individual data points shown and n = 2. Significance
values were determined using a one-way ANOVA test with a post hoc Tukey’s multiple comparisons test. ***, p , 0.001; ****, p , 0.0001. F, apoC-II fibrils were
formed at 30 °C for 72 h alone (56 mM) or in the presence of 12.8 mM of the indicated sHSP construct. These samples were then centrifuged as described above,
and the supernatant (Sup), sucrose (Suc), and pellet (P) layers were collected and analyzed by SDS-PAGE alongside a sample prior to centrifugation (total, T).
Also shown are control samples of each sHSP incubated alone under identical conditions.
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Figure 3. Fibril pelleting assay of preformed fibrils incubated with sHSP constructs. a-Syn fibrils (200 mM) were formed for 48 h at 37 °C, and apoC-II fibrils
(56 mM) were formed for 72 h at 30 °C. These preformed a-syn fibrils (A) and apoC-II fibrils (B) were then incubated alone or with the indicated sHSP at 10 mM
(for a-syn) or 12.8 mM (for apoC-II) for a further 72 h. Following this incubation, each sample was pelleted as described above, and the supernatant (Sup),
sucrose (Suc), and pellet (P) layers were collected and analyzed by SDS-PAGE alongside the total (T) uncentrifuged samples. Also shown are controls of each
sHSP construct incubated alone for 72 h and centrifuged as described above.

insufficient for fibril binding and that both the NTR and CTR
of Hsp27 have roles in fibril binding.
The time course of amyloid fibril binding by full-length and
NTR 1 ACD sHSP constructs
We next determined the time frame over which the fulllength sHSP constructs and Hsp27-3DDCTR associate with
both apoC-II and a-syn amyloid fibrils. Initially, preformed
apoC-II or a-syn fibrils were incubated with each construct for
0, 0.5, 2, or 6 h. We observed a gradual decrease in the amount
of WT aB-C detected in the sucrose layer over the incubation
period with both apoC-II and a-syn fibrils, coupled with a concomitant increase in the amount detected in the pellet fraction
(Fig. 4, A and B). Some WT aB-C remained in the sucrose fraction even after incubation for 6 h with apoC-II fibrils (Fig. 4B).
This suggests that the interaction of WT aB-C with amyloid
fibrils occurs slowly over the hour time scale. In contrast, the
majority of WT Hsp27 cosedimented with both fibril types at 0
h (Fig. 4, C and D), with only a small fraction remaining in the
sucrose fraction at 0 h in the presence of a-syn fibrils (Fig. 4C).
Hsp27-3D was identified only in the pellet fraction at 0 h and

remained in this fraction throughout the time course, suggesting that Hsp27-3D associated completely with apoC-II and
a-syn fibrils within the dead time of our assay (Fig. 4, E and F).
For Hsp27-3DDCTR, the majority of the protein was observed
in the pellet fraction at all incubation time points with both
fibril types (Fig. 4, G and H); however, we always observed a
faint band corresponding to Hsp27-3DDCTR in the supernatant, even after 72 h (Fig. 3, A and B). These results indicate
that WT Hsp27, Hsp27-3D, and Hsp27-3DDCTR rapidly associate with amyloid fibrils, whereas WT aB-C associates with
preformed fibrils slowly. Hsp27-3D may bind to a-syn fibrils
faster than WT Hsp27. The presence of a population of
unbound Hsp27-3DDCTR throughout the time course suggests
that its affinity for fibrils is reduced relative to the full-length
constructs.
The dissociation of apoC-II amyloid fibrils induced by sHSPs
Previous studies have shown that, at equilibrium, a free pool
of soluble protein exists in dynamic exchange with amyloid
fibrils (54). For apoC-II fibrils, this free pool accounts for ;5–
10% of the total protein concentration (55). Close inspection of
J. Biol. Chem. (2020) 295(29) 9838–9854
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Figure 4. Time course pelleting assay of preformed amyloid fibrils incubated with full-length sHSP constructs. a-Syn fibrils (200 mM ) were
formed for 48 h at 37 °C, and apoC-II fibrils (56 mM) were formed for 72 h at 30 °C. Fibrils were then incubated with the indicated sHSP construct at 10
mM (for a-syn) or 12.8 mM (for apoC-II) for 0–6 h. Following this incubation, each sample was centrifuged as described above. The supernatant (Sup),
sucrose (Suc), and pellet (P) layers were collected and analyzed by SDS-PAGE alongside the total (T) uncentrifuged samples. A–H, preformed a-syn
fibrils incubated with aB-C WT (A), WT Hsp27 (C), Hsp27-3D (E), and Hsp27-3DDCTR (G) and preformed apoC-II fibrils incubated with aB-C WT (B),
WT Hsp27 (D), Hsp27-3D (F), and Hsp27-3DDCTR (H). I and J, preformed a-syn or apoC-II fibrils and sHSP constructs incubated alone for 6 h at identical concentrations to those described above.

the fibril-binding time-course data (Fig. 4) showed a minor
band corresponding to apoC-II in the supernatant fraction in
the presence of the sHSPs (Fig. 4, B, D, F, and H) that was not
observed for apoC-II incubated alone (Fig. 4J). These findings
warranted a more quantitative study of the process of apoC-II
fibril dissociation and whether the presence of sHSPs affects
this process. We analyzed apoC-II fibrils incubated in the presence of WT aB-C for 0–20 h using SV-AUC (Fig. 5, B–D, and
Fig. S10). In this experiment, a rotor speed of 40,000 rpm
(129,000 3 g) was used because this centrifugal force causes the
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fibrils to pellet within minutes, whereas the oligomers formed
by WT aB-C and any soluble, monomeric apoC-II sediment
over a period of hours. This regime enables us to monitor the
relative proportions of both oligomeric WT aB-C and soluble,
monomeric apoC-II. The peak at ;1 S corresponds to monomeric apoC-II and is visible when fibrils are incubated alone
(Fig. 5B). However, with increasing incubation time in the presence of WT aB-C, the proportion of soluble apoC-II increases
(Fig. 5C). The peak at ;13 S, corresponding to oligomeric WT
aB-C, decreases with increasing incubation time (Fig. 5D). This
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Figure 5. Analysis of the time course of apoC-II fibril dissociation by WT aB-C. ApoC-II fibrils (56 mM) were formed for 72 h at 30 °C. A, fibrils were incubated
with WT aB-C (12.8 mM) for 0–24 h. Each sample was centrifuged as described above. The supernatant (Sup), sucrose (Suc), and pellet (P) layers were collected
and analyzed by SDS-PAGE alongside the total (T) uncentrifuged samples. B, SV-AUC analysis of preformed apoC-II fibrils (56 mM) incubated with WT aB-C
(12.8 mM) for 0 (red), 2 (orange), 4 (green), 8 (blue), or 20 (purple) h prior to SV-AUC. ApoC-II fibrils (black) and WT aB-C (brown) incubated alone for 20 h are also
shown. C and D, plots of the integral of the peak between 0.5 and 2 S (C) and between 8 and 22 S (D) in the c(s) distribution shown in B as a function of incubation time with WT aB-C. E, apoC-II fibrils (56 mM) formed with 10% S61C Alexa 488–labeled apoC-II were incubated with the indicated sHSP construct (12.8 mM)
for 24 h and centrifuged as described above. The supernatant fractions were analyzed by SDS-PAGE and imaged using a filter set for Alexa 488 as described
under “Experimental procedures.”

observation is consistent with an increasing proportion of
WT aB-C associating with the apoC-II fibrils over time
(Figs. 4 and 5A) because fibrils sediment too quickly to be
observed in this AUC experiment. Pelleting assays also demonstrated that WT Hsp27 and Hsp27-3D disaggregated
apoC-II fibrils in a concentration-dependent manner (Fig.
S11). To further assess apoC-II fibril dissociation, we
formed fluorescently labeled apoC-II fibrils using 10% S61C
Alexa 488–labeled apoC-II. These fibrils were incubated
alone or in the presence of each sHSP construct for 24 h.
The fibrils were pelleted, and the supernatant was analyzed
by SDS-PAGE without Coomassie Blue staining. Imaging
for Alexa 488–labeled apoC-II indicated that all sHSP con-

structs containing the NTR enhanced the proportion of
soluble apoC-II (Fig. 5E), whereas the ACD-only constructs
did not. Therefore, the NTR of Hsp27 and the terminal
regions of aB-C are important for apoC-II fibril dissociation. These results extend our previous findings that WT
aB-C enhances the dilution-induced dissociation of apoC-II
fibrils (38).
In contrast to our observations for apoC-II, pelleting
assays did not indicate that the proportion of soluble a-syn
in equilibrium with the fibrils was increased by the presence
of the sHSP constructs (Fig. 4, A, C, E, G, and I). Nevertheless, we tested the ability of WT aB-C to induce dissociation
of preformed a-syn fibrils using a pelleting assay (Fig. S12).
J. Biol. Chem. (2020) 295(29) 9838–9854
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Figure 6. SV-AUC analysis of preformed apoC-II fibrils (56 mM) incubated with various sHSP constructs. apoC-II fibrils (56 mM) were formed for 72 h,
30 °C. Subsequently, these fibrils were incubated either alone or with the indicated sHSP for a further 72 h, unless otherwise specified. In each panel, apoC-II
fibrils incubated alone is shown in black. ApoC-II fibrils were incubated with 12.8 mM WT aB-C (A), 12.8 mM aB-C ACD (B), 12.8 mM WT Hsp27 (C), 12.8 mM Hsp27
ACD (D), 12.8 mM Hsp27-3D (E), 6.4 mM Hsp27-3D (F), 12.8 mM WT Hsp27 for 0 h (G), and 12.8 mM Hsp27-3DDCTR (H).

This experiment shows no observable dissociation of a-syn
fibrils by WT aB-C under the conditions and time scales
that we tested in this work. Longer incubation times or additional factors such as dilution or ATP-dependent HSPs may
be required for the dissociation of a-syn fibrils, as has previously been observed (56, 57).
The effects of fibril binding by sHSPs on the size distributions
of preformed amyloid fibrils
We next determined the effect of sHSPs on the size distributions of preformed apoC-II fibrils using SV-AUC (Fig. 6,
Figs. S13–S17, and Tables S3–S7). The interaction of WT
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aB-C with apoC-II fibrils resulted in an increase in the
weight-average fibril sedimentation coefficient as indicated
by a shift in the sedimentation coefficient distribution toward
higher S values (Fig. 6A). We interpret this as an increase in
the lateral association of mature fibrils with one another
mediated by WT aB-C. In contrast, aB-C ACD, which did
not stably colocalize with apoC-II fibrils (Fig. 3B), did not
increase the weight-average sedimentation coefficient of the
fibrils. Instead we observed a small but reproducible shift in
the sedimentation coefficient distributions toward smaller S
values (Fig. 6B). Similarly, WT Hsp27 increased, and Hsp27
ACD decreased, the average size of the fibrils (Fig. 6, C and
D). The binding of Hsp27-3D to apoC-II fibrils resulted in
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immediate and visible precipitation such that, when present
at the same concentration as the other sHSP constructs (12.8
mM), the fibrils sediment too rapidly to accurately determine
the sedimentation coefficient distributions (Fig. 6E and Fig.
S14D). At a lower concentration (6.4 mM), the binding of
Hsp27-3D to the fibrils also results in a large increase in the
fibril size distribution (Fig. 6F, Fig. S15B, and Table S5).
Given the observation that full-length Hsp27 constructs
appear to bind fibrils faster than our methodologies allow us
to detect (Fig. 4, D and F) and that Hsp27-3D resulted in the
visible precipitation of apoC-II fibrils within a matter of
minutes, we also tested the effect of WT Hsp27 on the size
distribution of preformed apoC-II fibrils after a shorter incubation period, immediately after the addition of Hsp27 (Fig.
6G, Fig. S16, and Table S6). The resulting fibril size distribution closely matched that observed after 72 h. The duration of
the AUC experiment is ;5–6 h; therefore, this result indicates that the lateral fibril–fibril association caused by WT
Hsp27 primarily occurs within the first few hours after the
addition of the sHSP to the fibrils. Interestingly, despite the
stable interaction of Hsp27-3DDCTR with preformed fibrils
(Fig. 3B), this construct did not increase the size distributions of the apoC-II fibrils to the same extent as the fulllength Hsp27 constructs (Fig. 6, C, F, and H, Fig. S17, and
Table S7). This result suggests that the CTR region of Hsp27
plays an important role in promoting lateral association
and/or tangling of apoC-II fibrils. Incubation of BSA, a nonchaperone control, with preformed apoC-II fibrils did not
result in a change to the weight-average fibril sedimentation
coefficient (Fig. S18 and Table S8). Thus, full-length Hsp27
constructs, WT aB-C, and to a lesser extent Hsp27-3DDCTR
increase the size distributions of apoC-II fibrils. This apparent
increase in size is likely due to fibril cross-linking mediated by
the sHSP, as has been previously observed using WT aB-C (38).
The ACD constructs do not exert this effect, which is consistent
with our observation that the ACD constructs do not bind stably
to apoC-II fibrils (Fig. 3B). The lateral fibril–fibril association
observed in the presence of full-length sHSPs using AUC was
further confirmed using TEM (Fig. S19). Preformed fibrils incubated alone or in the presence of the ACD-only constructs
appeared relatively dispersed on the EM grids, whereas those
incubated in the presence of WT aB-C, WT Hsp27, or Hsp273D appeared to form denser fibril tangles (Fig. S19).
Because a-syn fibrils are too large for SV-AUC analysis, even
at the lowest available rotor speed, we monitored the assembly
of a-syn fibrils into larger aggregates mediated by the various
sHSP constructs by light scattering over a period of up to 6 h.
Using this approach, a time-dependent increase in the light
scattering of a-syn fibrils incubated in the presence of all fulllength sHSPs was detected but not with Hsp27-3DDCTR or the
ACD-only sHSPs (Fig. 7A). Full-length Hsp27 and Hsp27-3D
induced an increase in light scattering within 30 min, whereas
the increase in light scattering induced by WT aB-C occurred
over 2 h. These observations are consistent with the rate of
a-syn fibril binding by these full-length sHSPs observed in our
pelleting assays (Fig. 4), suggesting that fibril binding and the
formation of larger fibrillar aggregates are related processes.
That we could not detect an increase in turbidity of a-syn fibrils

Figure 7. Analysis of light scattering by a-syn amyloid fibrils in the presence of sHSPs. a-Syn fibrils (200 mM) were formed for 48 h at 37 °C. A, absorbance measurements at 360 nm of preformed a-syn fibrils incubated alone
(black) or in the presence of 10 mM WT aB-C (red), aB-C ACD (green), WT
Hsp27 (orange), Hsp27 ACD (blue), Hsp27-3D (magenta), or Hsp27-3DDCTR
(cyan) for up to 6 h. B, turbidity measurements for buffer alone (gray), for preformed a-syn fibrils incubated alone (black), and for preformed a-syn fibrils
in the presence of 10 mM WT aB-C (red), 10 mM WT Hsp27 (orange), and 10 mM
Hsp27-3D (magenta). The data are presented as means 6 S.E. where n = 3. C,
analysis of the time taken for half-maximal change in turbidity (t1/2) of a-syn
fibrils incubated with WT Hsp27 (orange) or Hsp27-3D (magenta) derived
from fits to the raw data in B using a four-parameter sigmoidal Hill plot. The
data are presented as the means 6 S.D. with the individual data points
shown and n = 3. A paired t test was used to compare the t1/2 for WT Hsp27
versus Hsp27-3D. **, p , 0.01.

incubated with Hsp27-3DDCTR is consistent with the observation that this construct did not cause lateral association of
apoC-II fibrils to the same extent as the full-length Hsp27 constructs, providing further evidence that the CTR of Hsp27 is important for this chaperone function. We subsequently used
a continuous assay to more accurately track the increase in light
scattering mediated by the presence of sHSPs. WT aB-C did not
induce a significant increase in light scattering over the first 20
min of incubation (Fig. 7B), consistent with its slower rate of fibril
binding. The turbidity of a-syn fibrils incubated with Hsp27-3D
increased more rapidly than that of fibrils incubated with WT
Hsp27 (Fig. 7, B and C, Fig. S20, B–G, and Table S9). These
results are also consistent with our observation that Hsp27-3D
may bind a-syn fibrils more rapidly than WT Hsp27 (Fig. 4, C
and E). Overall, these light-scattering experiments support our
observations that by binding to fibrils, full-length sHSPs mediate
their association into larger aggregates. To further confirm that
the full-length sHSP constructs induced lateral fibril–fibril association of a-syn fibrils, we used TEM (Fig. S21). a-syn fibrils incubated alone or in the presence of ACD-only sHSPs appeared dispersed on the grids, whereas those incubated in the presence of
WT aB-C, WT Hsp27, or Hsp27-3D appeared as larger networks
of tangled fibrils (Fig. S21). Fibrils incubated in the presence of
Hsp27-3DDCTR appeared to form slightly larger fibril tangles
than those observed for a-syn fibrils incubated alone.
J. Biol. Chem. (2020) 295(29) 9838–9854
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Discussion
It is well-established that the human sHSPs Hsp27 and aB-C
are molecular chaperones that inhibit the aggregation of a wide
range of client proteins (8, 35, 37, 40). Over the past decade, significant progress has been made in understanding the hierarchical interactions that regulate the oligomerization of aB-C and
Hsp27. An interchain b-sheet formed between two ACDs
mediates dimerization (2), the CTR interacts with the ACD of
adjacent dimers to facilitate the formation of small oligomers
(4, 58), and varied interactions involving the NTR regulate
higher-order oligomerization (4). Recent work suggested that
the isolated ACD of aB-C, which forms a stable dimer, retains
chaperone activity comparable with that of the full-length protein (5). Although there is not yet a clear consensus regarding
how Hsp27 or aB-C interact with client proteins to inhibit or
delay their aggregation, potential substrate-binding sites have
been identified within the N- and C-terminal regions, as well as
in the ACD (46, 48, 59). To determine the roles that the NTR,
ACD, and CTR play in inhibiting amyloid fibril formation, we
compared the relative chaperone activities of an array of fulllength and truncated constructs of Hsp27 and aB-C against
amyloid fibril formation by two disease-associated proteins:
apoC-II and a-syn. Importantly, although the ACD-only constructs retain some ability to delay amyloid fibril formation,
they lack several specific chaperone properties that we show
are conferred by the NTR and CTR. We found that the NTR of
Hsp27 and the terminal regions of aB-C are important for
delaying the early stages of amyloid formation, for allowing
sHSPs to associate with amyloid fibrils, and for inducing apoCII amyloid fibril disaggregation. The CTR of Hsp27 and either
or both of the terminal regions of aB-C were implicated in the
lateral association of fibrils that comes about through sHSPs
binding stably to fibrils.
We used ThT assays and fibril pelleting assays to assess the
relative chaperone abilities of several constructs of aB-C and
Hsp27. In the unseeded amyloid fibril formation assays, we
observed several differences between the final ThT yields for
apoC-II or a-syn fibrils formed in the presence of the aB-C
constructs compared with the Hsp27 constructs. However, the
a-syn pelleting assay showed no difference in the fraction of
aggregated a-syn in the presence of these two sHSP constructs.
Furthermore, the pelleting assay performed at the end of
unseeded apoC-II fibril formation also indicated that despite
differences in the final ThT fluorescence yields, the presence of
WT aB-C, WT Hsp27, or Hsp27-3D all resulted in a substantial
amount of apoC-II remaining soluble. TEM confirmed the formation of a-syn fibrils in the presence of all of the sHSP constructs and of apoC-II fibrils in the presence of WT aB-C and
Hsp27-3D. We hypothesize that the differences in ThT fluorescence could be due to differences in the colocalization of the
sHSPs with the fibrils, which may differentially affect the binding of ThT to the fibrils and therefore ThT fluorescence. Alternatively, the various sHSP constructs may induce changes in
fibril morphology. It is known that a-syn fibrils exist in various
polymorphs (60). It is plausible that these polymorphs bind
ThT to differing extents. Another explanation is that the differences in ThT fluorescence we observe are due to differences in
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the lateral association of the fibrils, induced by the sHSPs, as
the fibrils form. This work shows that this lateral fibril–fibril
association occurs more slowly in the presence of WT aB-C
than for WT Hsp27. The fluorescence yields observed in ThT
assays should therefore be interpreted cautiously and verified
using orthogonal methodologies, particularly for investigations
of molecules that may bind or alter the morphology of the
aggregates. Thus, for this work we used ThT fluorescence as a
reporter of the duration of the lag phase and the T50 in combination with pelleting assays and TEM.
Across all of our fibril formation assays, the full-length and
NTR 1 ACD constructs were superior chaperones compared
with the ACD-only constructs. Only constructs containing the
NTR significantly increased the Tlag for a-syn fibril formation.
ACD-only constructs were also less effective at delaying a-syn
and apoC-II fibril elongation than those with the NTR. WT
Hsp27, Hsp27-3D, and Hsp27-3DDCTR delayed fibril nucleation and elongation by both a-syn and apoC-II to similar
extents, indicating that neither the formation of high-molecular-weight Hsp27 oligomers nor the CTR of Hsp27 are required
for delaying amyloid formation. Taken together, our results
indicate that the NTR of Hsp27 and the terminal regions of
aB-C play essential roles in delaying the nucleation phase of
amyloid formation and contribute to reducing the rate of fibril
elongation.
Pelleting assays with preformed fibrils demonstrated that
full-length and NTR 1 ACD constructs disaggregate apoC-II
amyloid fibrils; in contrast, we did not observe apoC-II fibril
dissociation induced by the ACD-only constructs. It is likely
that by interacting with a soluble form of apoC-II that exists in
equilibrium with the fibrils, these sHSP constructs shift the
equilibrium in favor of fibril dissociation. This mechanism
agrees with previous work investigating the inhibition of apoCII and a-syn amyloid formation by WT aB-C (38, 40). Interestingly, AUC data showed that the release of soluble apoC-II
monomers from apoC-II fibrils occurred at a similar rate to the
binding of WT aB-C to fibrils, suggesting a possible correlation
between fibril binding by sHSPs and the process of fibril dissociation. Our data cannot rule out promotion of fibril disaggregation, at least in part, resulting from destabilization of apoC-II
fibrils through direct interaction of the sHSPs with the fibrils.
The interaction of sHSPs with preformed protein aggregates
has been proposed not only to inhibit fibril elongation but also
to reduce the cytotoxicity of fibrils, either by coating the aggregates and reducing their reactive surface area (61) or by sequestering them into larger inclusion body–like structures (38). The
assay conditions used in this study do not favor secondary
nucleation processes (52); thus, we can only speculate as to how
the interactions of sHSPs with preformed fibrils might affect
this process. It is likely that the stable binding of fibrils by
sHSPs and the lateral fibril–fibril associations induced by the
sHSPs observed in this study would reduce the surface area of
the fibrils available for secondary nucleation processes. The stable interaction of WT aB-C with apoC-II and Ab fibrils has
been observed previously (35, 38), as has an interaction
between WT aB-C, WT Hsp27, and Hsp27-3D with a-syn
fibrils (40, 53). Here, we have observed that the stable interaction of sHSPs with preformed amyloid fibrils depends on
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Figure 8. Two models for the mechanism of fibril binding and lateral
tangling induced by sHSPs. The domains of sHSPs are colored as follows:
NTR (black), ACD (red), and CTR (blue). Amyloid fibrils are depicted in brown.
In the first model, both the NTR and CTR contribute directly to fibril binding.
In the absence of the CTR, an individual sHSP dimer has a reduced fibril-binding affinity and a reduced ability to cause lateral fibril association. In the second
model, the CTR of one sHSP that is bound to fibrils via its NTR docks onto the
ACD of another fibril-bound sHSP. This CTR-mediated oligomerization results in
tangling of the associated fibrils. In the absence of the CTR, CTR–ACD interactions cannot form, and this type of sHSP oligomerization is not possible.

sequences within the NTR and CTR. Our pelleting assays
showed that only the full-length and NTR 1 ACD constructs
interacted with both elongating and mature apoC-II and a-syn
fibrils. In these assays, the NTR 1 ACD construct appeared to
have a reduced capacity to cosediment with both types of
fibrils, indicating that the CTR must also contribute to fibril
binding directly (i.e. through a direct CTR-fibril interaction) or
indirectly (i.e. via a CTR-sHSP interaction) (Fig. 8). Although
we were unable to detect any stable interaction between the
ACD-only constructs and apoC-II fibrils, we did observe an
interaction between aB-C ACD and elongating a-syn fibrils.
However, when aB-C ACD was added to preformed a-syn
fibrils, this interaction was not observed. This suggests that aBC ACD can interact with some element present when a-syn
fibrils are elongating, but not once they are formed. The fact
that Hsp27 ACD did not form stable interactions with elongating a-syn fibrils suggests differences in the interaction between
these two ACD-only constructs and a-syn.
We found that WT Hsp27 binds fibrils more rapidly than
WT aB-C, and this capacity is further enhanced in Hsp27-3D.
Assuming that dissociated sHSP species (e.g. dimers) are the
predominant fibril-binding species, the difference in the rate of
fibril binding observed between WT aB-C and WT Hsp27 may
be due to differences in the rate of dissociation of sHSP dimers
from their oligomeric form and/or the rate of fibril binding by a
sHSP dimer. WT Hsp27 binds to fibrils over a period of
minutes, whereas WT aB-C binds over a period of hours,
meaning that the rate of fibril binding by a Hsp27 dimer is
greater than that of aB-C, that the rate of Hsp27 dimer dissociation from a Hsp27 oligomer is faster, or a combination of both
of these effects. Hsp27-3D and Hsp27-3DDCTR both appeared
to interact with fibrils faster than WT Hsp27, and this difference is most likely due to differences in the quaternary struc-

ture of these constructs. Hsp27-3D and Hsp27-3DDCTR primarily exist as dimers in solution (51), which we confirmed
here by AUC (Fig. S4). Thus, for Hsp27-3D and Hsp273DDCTR, fibril binding can be considered a one-step process,
the rate of which depends only on the rate at which dimers
bind to fibrils, independent of sHSP oligomer dissociation.
Our fibril-binding studies revealed that the full-length and
NTR 1 ACD constructs increased the weight-average sedimentation coefficient of apoC-II fibrils, suggesting formation
of large fibril aggregates through lateral fibril–fibril association.
Full-length Hsp27 constructs, particularly Hsp27-3D, were
more effective at binding and lateral association of apoC-II
fibrils than WT aB-C and Hsp27-3DDCTR. Both full-length
Hsp27 constructs rapidly enhanced the turbidity of the a-syn
fibril sample, whereas WT aB-C enhanced the turbidity of the
fibril sample over a longer time frame. Additionally, both WT
Hsp27 and Hsp27-3D increased the weight average sedimentation coefficient of apoC-II fibrils to a far greater extent than
WT aB-C. Under the assumption that sHSPs interact reversibly with preformed fibrils, each cycle of fibril binding has the
potential to bring two or more fibrils in close proximity. Therefore, the capacity of each sHSP construct to induce lateral
fibril–fibril association could be dependent upon the rate at
which they bind, dissociate from, and reassociate with fibrils.
The slower rate at which WT aB-C enhanced the turbidity
of the a-syn fibrils and the reduced extent to which it enhanced
the size distribution of apoC-II fibrils are likely due to its substantially slower rate of fibril association relative to the Hsp27
constructs. Because Hsp27-3DDCTR was also less effective
than the full-length Hsp27 constructs at lateral association of
apoC-II fibrils and increasing the light scattering of a-syn
fibrils, we conclude that the CTR of Hsp27 is important for this
component of the interaction between sHSPs and amyloid
fibrils. Two distinct mechanisms may account for these observations (Fig. 8). It is possible that the two NTRs present on fulllength sHSP dimers each interact simultaneously with two separate fibrils, resulting in the lateral association of these fibrils.
In this model, the CTR may also be directly involved in binding
to additional fibrils, and therefore when this domain is absent,
the fibril-binding affinity is reduced, reducing the extent to
which the sHSPs can induce lateral association of the fibrils. An
alternative explanation is that the CTR does not make direct
contact with fibrils but instead engages another fibril-bound
sHSP dimer via a CTR–ACD interaction (Fig. 8), indirectly
resulting in lateral association of the bound fibrils. The CTR is
important for the hierarchical assembly of sHSP oligomers via
its docking interaction with the ACD of neighboring subunits
(58). In this case, because Hsp27-3DDCTR cannot form these
CTR-mediated dimer–dimer interactions, it has a reduced ability to tangle the fibrils.

Conclusion
A variety of classes of HSPs have been shown to form stable
associations with amyloid fibrils (61), suggesting that this phenomenon may play a cytoprotective role. The expression levels
of sHSPs are increased in the mammalian brain during aging
(62), and sHSPs are known to associate with senile plaques and
J. Biol. Chem. (2020) 295(29) 9838–9854
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Lewy bodies (63–65). These factors necessitate a detailed
understanding of how sHSPs interact with amyloid fibrils and
what the consequences of these interactions are in vitro. Using
two distinct disease-associated proteins that form fibrils, we
observed that the ACDs of aB-C and Hsp27 were less effective
at delaying amyloid fibril nucleation and elongation than fulllength and NTR 1 ACD constructs. Only the full-length and
NTR 1 ACD constructs were able to significantly delay amyloid fibril nucleation and disaggregate preformed apoC-II
fibrils. Importantly, we show that sequences within the NTR of
Hsp27 and the terminal regions of aB-C are required for the
association of these sHSPs with preformed amyloid fibrils and
their ability to induce disaggregation. The CTR of Hsp27
appears to play an important role in mediating the association
of fibrils into larger aggregates. There is growing evidence that
the sequestration of small protein aggregates into much larger
aggregates, called aggresomes, is cytoprotective (66). The formation of an aggresome limits the cytotoxicity of aggregates
spatially while also reducing their reactive surface area. There is
also evidence that aggresome formation can enable asymmetric
inheritance of protein aggregates in dividing cells (66). Our
work demonstrates that the terminal regions of sHSPs are important for this potentially cytoprotective role in vivo.
Overall, the results of this study show that sHSPs interact
with various species formed during the aggregation of a protein
into amyloid fibrils and that they do so via multiple distinct
binding sites involving the N- and C-terminal regions, as well
as the ACD. Thus, the ACD alone is not sufficient for all of the
chaperone activities exhibited by the full-length protein. This
work expands our understanding of the roles of the N- and Cterminal regions of human sHSPs in interacting with proteins
that form amyloid. This increased understanding of the mechanisms and consequences of sHSP interactions with amyloid
fibrils has important implications in the pathogenesis and progression of diseases associated with amyloid deposition.

II) or 4 h (a-syn and all sHSPs). The cultures were harvested by
centrifugation and resuspended in 400 ml (apoC-II) or 40 ml
(a-syn, WT aB-C, Hsp27 WT, Hsp27-3D) of TN buffer (50 mM
Tris, 100 mM NaCl, pH 8.0) or 40 ml (aB-C ACD, Hsp27 ACD)
TNI buffer (20 mM Tris, 40 mM imidazole, 500 mM NaCl, pH
8.0) and stored at 220 °C until use.
ApoC-II purification was performed as previously described
(22); however, anion-exchange chromatography was performed in 6 M urea, 10 mM Tris, pH 8.0 using DEAE SephacelTM
resin prior to size-exclusion chromatography (SEC). Purification of a-syn was performed according to published methods
(69) with an additional SEC chromatography step performed in
6 M urea, 10 mM Tris, pH 8.0, using a 500-ml XK26/60 chromatography column packed with Sephacryl® S200-HR resin. Purified a-syn was lyophilized and resuspended in 6 M guanidine
hydrochloride. The purification of Hsp27 WT and aB-C WT
was performed as previously described (68). The purification of
Hsp27-3D was performed in an identical manner, with the
addition of a hydrophobic interaction chromatography step
using a HiLoad 26/10 Phenyl-Sepharose High Performance
hydrophobic interaction chromatography column prior to
SEC. The protein was loaded using 50 mM sodium phosphate,
pH 7.4, 750 mM ammonium sulfate and eluted using a gradient
from 50 mM sodium phosphate, pH 7.4, to distilled H2O over
15 column volumes. The purification of aB-C ACD and Hsp27
ACD was performed as previously described (2). Hsp273DDCTR was purified according published methods used to
purify WT Hsp27 (70). The purity of all protein stocks was
determined to be ≥90% using SDS-PAGE and MS. Guanidine
hydrochloride stocks of apoC-II and a-syn were stored at
220 °C at ;30–50 mg/ml (apoC-II) and 100–150 mg/ml
(a-syn). Stocks of all sHSPs (100–300 mM) were stored for longterm use at 280 °C or at 4 °C for short-term use (,4 weeks).

Experimental procedures

ApoC-II and a-syn were rapidly diluted from guanidine
hydrochloride stocks into fibrillation buffer (0.1 M sodium
phosphate, pH 7.4, 0.1% sodium azide) to generate monomeric
stocks immediately prior to each experiment. These monomeric stocks were aliquoted into wells of a clear, flat-bottomed
96-well tissue culture plate to a final concentration of 56 mM
(apoC-II) or 200 mM (a-syn). For ThT assays, 10 ml of a 100 mM
ThT stock (prepared in 0.1 M sodium phosphate, pH 7.4, 0.1%
sodium azide) was also added along with the required volume
of the relevant sHSP or a matching volume of buffer. The total
assay volume in each case was 100 ml. The final concentration
of guanidine hydrochloride was ;66 mM in the apoC-II assays
and 115 mM in the a-syn assays. The plates were incubated in a
FLUOstar® Omega microplate reader (BMG Labtech, Melbourne, Australia) for up to 200 h. For unseeded apoC-II fibril
formation, the plates were incubated at 30 °C without shaking.
For unseeded a-syn fibril formation, a 2-mm diameter glass
bead (Sigma–Aldrich) was added to each well to ensure mixing.
The plates were incubated at 37 °C with orbital mixing at 700
rpm during the incubation. For seeded a-syn fibril formation,
fibrils formed using the unseeded method were sonicated on

Protein expression and purification
A pET11a vector encoding for apoC-II expression, pET24a
vectors encoding human a-syn, aB-C ACD (residues 68–153),
Hsp27 ACD (residues 84–175), or aB-C and pET3a vectors
encoding human Hsp27, Hsp27-3D (with S15D, S78D, and
S82D mutations), and Hsp27-3DDCTR (residues 1–175 with
S15D, S78D, and S82D mutations) were used for expression of
these proteins. Tobacco etch virus protease with L56V and
S135G stabilizing mutations was expressed and purified
according to the methods developed by Cabrita et al. (67). The
expression and purification of WT apoC-II, WT a-syn, WT
aB-C, aB-C ACD, WT Hsp27, Hsp27 ACD, Hsp27-3D, and
Hsp27-3DDCTR were all performed using modified protocols
from previously published work (2, 22, 68–70).
All liquid cultures used for expression were incubated at
37 °C with shaking at 200 rpm. The expression of recombinant
proteins was initiated by the addition of isopropyl-b-D-thiogalactopyranoside to a final concentration of 1 mM (apoC-II) or
0.5 mM (a-syn and all sHSPs) when the A600 of cultures reached
0.8. The cultures were then incubated at 37 °C for 2.5 h (apoC-
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ice using a Q500 probe sonicator (Qsonica, Newtown, CT) for
14 rounds of 30-s on/off pulses at an amplitude of 20%. This
seed fibril stock was added to fresh, monomeric a-syn to a concentration of 5% of the total a-syn concentration. The mixture
was incubated in the microplate reader at 45 °C for up to 30 h
without shaking. ThT fluorescence was measured using excitation and emission filters of 440 and 480 nm, respectively.
At the end of unseeded a-syn fibril formation, the data for the
change in ThT fluorescence over time were fitted with Boltzmann sigmoidal curves using GraphPad Prism version 8 (GraphPad Software Inc., San Diego, CA). Parameters from these fits
were used to estimate the length of the lag phase using equations
previously derived (71). The equation of the Boltzmann curve is,

F 5 Fi þ

Ff 2 Fi
T50 2 T
1 1 eð k Þ

Fluorescent apoC-II fibril pelleting assay

(Eq. 1)

where F is the fluorescence intensity at a given time point, T
(in units of hours), Fi is the initial fluorescence intensity, Ff
is the final fluorescence intensity, T50 is the time to halfmaximal change in ThT fluorescence, and k is a factor relating
to the steepness of the change in ThT fluorescence. The equation
used to derive estimates of the lag time (Tlag) is as follows.

Tlag ¼

4kFi
1 T50 2 ð2k Þ
Ff 2 Fi

(Eq. 2)

At the end of seeded a-syn fibril formation and unseeded
apoC-II fibril formation, the data for the change in ThT fluorescence over time were fit with one-phase association curves
using GraphPad Prism version 8. The equation for the onephase association model is,

F ¼ Fi 1 ðFf 2 Fi Þ 1 2 eðkT Þ
(Eq. 3)
where F is the fluorescence intensity at a given time point (T,
in units of hours), Fi is the initial fluorescence intensity, Ff is
the plateau in fluorescence intensity, and k is a factor relating
to the steepness of the change in ThT fluorescence. The equation used to derive estimates of the T50 is as follows.

T50 5 ln 2=k

exception that ThT was omitted from the buffers. apoC-II and
a-syn fibrils were separated from monomeric apoC-II, monomeric a-syn, oligomeric sHSPs, and dimeric sHSPs using centrifugal force according to an established protocol (38). Briefly,
100-ml aliquots of each sample were layered on top of 100 ml of
20% (w/v) sucrose dissolved in fibrillation buffer. The samples
were centrifuged at 385,000 3 g at 20 °C for 30 min (TLA-100
rotor OptimaMax centrifuge, Beckman Coulter, Brea, CA). The
top 80 ml of the supernatant and the bottom 80 ml of the sucrose
layers were collected, and the pellets were resuspended in 100
ml of fibrillation buffer. The total noncentrifuged, supernatant,
sucrose, and pellet fractions were analyzed by SDS-PAGE.

(Eq. 4)

Fits to the raw data were only used for downstream analysis
when the goodness of fit as estimated by R2 values was .0.97.
To analyze the statistical significance of the difference in the
mean T50 and Tlag values derived from fits to the raw data, oneway ANOVA tests with post hoc Tukey’s multiple comparisons
tests were performed using GraphPad in Prism version 8.
The time course of fibril formation by a-syn and apoC-II differ
substantially across these three assays. For each of these assays,
we selected the sHSP concentrations at which chaperone activity
was observed, but complete inhibition was not observed. The
sHSP concentrations were therefore consistent within a given
assay but differed between the three amyloid formation assays.
Fibril pelleting assays using a sucrose cushion
Fibril formation for pelleting assays was performed in a manner identical to that described for the ThT assays with the

Separate guanidine hydrochloride stocks of WT unlabeled
apoC-II and S61C Alexa 488–labeled apoC-II prepared as
described previously (72) were rapidly diluted into fibrillation
buffer at a ratio of 9:1 WT:S61C Alexa 488 to a total apoC-II
concentration of 0.5 mg/ml. This mixture was incubated at
30°C for 1 week to allow fibrils to form. Preformed fibrils were
aliquoted and incubated alone or in the presence of each sHSP
construct at 30°C for a further 24 h. 80-ml aliquots of each incubation were centrifuged as described above without a sucrose
layer. 20 ml was kept as the total uncentrifuged sample. The supernatant and pellet layers were collected. The supernatant
fractions were analyzed by SDS-PAGE without Coomassie Blue
staining, and the gels were imaged immediately using a ChemiDoc MP imaging system (Bio-Rad) with the Pro-Q Emerald 488
application (530/28 filter set). The total and pellet layers were
analyzed in the same way but on separate gels.
Sedimentation velocity analysis
For all AUC experiments, samples of 380 ml were loaded into
one sector of a 12-mm double-sector epon-filled centerpiece,
and 400 ml of the relevant reference solution was loaded into
the other sector of the cell. Radial absorbance scans at appropriate wavelengths were taken using an XL-1 analytical ultracentrifuge (Beckman Coulter) equipped with a Ti50 rotor at
20 °C, collecting scans at 4-min intervals with a radial step size
of 0.003 cm. SV-AUC of apoC-II fibrils incubated with WT aBC for 0–20 h was analyzed at a rotor speed of 40,000 rpm
(129,000 3 g) with a detection wavelength of 232 nm. The continuous sedimentation coefficient distribution c(s) model using
regularization by maximum entropy was used to fit SV-AUC
data for oligomeric sHSPs and monomeric apoC-II (73). The
area under peaks in the c(s) distributions were obtained by integrating the distributions over the specified range using the
SEDFIT software (73). SV-AUC data for Hsp27 ACD, Hsp273D, and Hsp27-3DDCTR were acquired using a rotor speed of
50,000 rpm (201,600 3 g) with detection wavelengths of 233 or
280 nm. SV-AUC data for Hsp27 WT were acquired using a
rotor speed of 40,000 rpm (129,000 3 g) and a detection wavelength of 237 nm. The buffer density (r), buffer viscosity (h),
and partial specific volume (v ) used for the analysis of Hsp27
WT, Hsp27 ACD, Hsp27-3D, and Hsp27-3DDCTR were calculated using the SEDNTERP software (version 14.6e) (74). SVAUC of apoC-II fibrils was analyzed at 8,000 rpm (5,161 3 g)
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using detection wavelengths between 280 and 290 nm. The c(s)
distributions were obtained by fitting the data using SEDFIT
and a worm-like chain model described previously (75) using
Tikhonov–Phillips regularization by second derivative (73, 76).
Turbidity assays
For assays conducted in a FLUOstar® Omega microplate
reader, aliquots of 100 ml of a-syn fibrils were incubated at
37 °C without shaking in the presence or absence of the various
sHSP constructs. Optical density was recorded using a 355-nm
filter for up to 25 min at 20-s intervals. The time to half-maximal change in fibril optical density was determined by fitting
the raw data to a four-parameter sigmoidal Hill equation,


at b
(Eq. 5)
OD ¼ OD0 1 b
c 1 tb
where OD is the optical density and a given time (t, in min),
OD0 is the optical density at time 0, a is the difference between
the final and initial optical density, c is the time to half-maximal change in optical density, and b is a scaling factor relating
the steepness of the curve. For assays conducted using a
DU800 spectrophotometer (Beckman Coulter), absorbance
measurements of 100 ml of a-syn fibrils incubated in the presence or absence of the various sHSP constructs were recorded at
360 nm at the indicated time point after the addition of the
sHSP. The path length was 10 mm, and at each time point a reference sample was used to obtain absorbance in arbitrary units.
Transmission electron microscopy
Carbon-coated Formvar 300 mesh copper grids were glowdischarged under reduced atmospheric pressure for 30 s at 25
mA. ApoC-II samples were diluted to ;11 mM in distilled H2O.
a-syn samples were diluted to ;20 mM in distilled H2O. 4-ml
aliquots of diluted samples were adsorbed onto the grid for 60
s. The samples were blotted using filter paper, and the grids
were stained twice with 4 ml of 2% potassium phosphotungstate, pH 6.8, and air-dried. The grids were observed at the
Bio21 Institute Advanced Microscopy Facility under a Talos
L120C TEM (Thermo Fisher Scientific) operating at 120 kV.
The images were captured digitally using a Ceta 16M digital
camera (Thermo Fisher Scientific).

Data availability
All data are contained within the manuscript and supporting
information.
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